Oxford, United Kingdom

Mostyn Embrey

This inventor holds 1 USPTO granted patent. Top assignee: Lloyds Bank Plc. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mostyn Embrey: Innovator in Controlled Release Compositions

Introduction: Mostyn Embrey is a notable inventor based in Oxford, Great Britain. He has made significant contributions in the field of pharmaceuticals, specifically focusing on controlled release formulations. With a unique patent to his name, Embrey stands out in the realm of innovation.

Latest Patents: Mostyn Embrey holds a patent for "Controlled release compositions (II)". This invention details a controlled release composition that comprises a prostaglandin and a polymeric carrier. The carrier is characterized by residues that have a number average molecular weight to functionality ratio greater than 1,000, incorporating polyethylene oxide and being cross-linked through urethane groups. This innovation has potential applications in enhancing the effectiveness of drug delivery systems.

Career Highlights: Currently, Mostyn Embrey works for Lloyds Bank Plc, where he likely contributes his expertise in understanding the intersection of finance and innovation. His role within this institution reflects a blend of technical knowledge and corporate acumen.

Collaborations: During his career, Mostyn has had the pleasure of collaborating with Neil B. Graham, a fellow coworker. Their partnership may have provided unique insights into the development of life-enhancing technologies.

Conclusion: Mostyn Embrey exemplifies the spirit of innovation with his work on controlled release compositions. As he continues to engage in his career at Lloyds Bank Plc, his contributions to the field of drug formulation undoubtedly help shape the future of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…